BioSpace News Archive

Officials from Health Canada will hold a technical briefing to discuss the response to Notices of Objection to the Final Re-evaluation Decision for Glyphosate.

InMed Pharmaceuticals Inc. today announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member of the Scientific Advisory Board (“SAB”) and, contemporaneously, announced his retirement as Chief Scientific Officer (“CSO”). Dr. Eric C. Hsu, PhD, Vice President, Pre-Clinical Research & Development, will continue to lead the scientific R&D programs of the Company.

Conference brings together global leaders in medical cannabis science, finance, agri-tech and policy

Acquisition enhances Cantel’s Dental water solutions portfolio and advances global leadership position in infection prevention

The West Virginia Mesothelioma Victims Center says, “We are now urging a person anywhere in West Virginia who has just been diagnosed with mesothelioma and asbestos exposure lung cancer or their family to call us anytime at 800-714-0303 for direct access to nationally renowned mesothelioma attorney Erik Karst founding partner of Karst von Oiste.

Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that Olaregen Therapeutix Inc., a subsidiary of Generex Biotechnology will launch three doses of FDA 510K-Cleared Excellagen, the company’s wound conforming gel matrix that is designated as a Cellular & Tissue Based Product or CTP for wound healing.

The Developmental Disabilities Council of Oklahoma (the Council), which promotes quality services and programs that enable persons with disabilities to fully realize their maximum potential through increased independence and community inclusion, is proud to announce an updated look and feel for their image.

A leading market intelligence solutions provider, Infiniti Research, has announced the completion of their market entry strategy for a medical devices industry client

AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, received reaccreditation* from URAC for its specialty pharmacy services.

Burst Biologics is pleased to announce an exciting new partnership with Adventist Health System, a faith-based health care organization centered on quality, safety, and patient satisfaction.